Giovanni Orsolini
Publication Activity (10 Years)
Years Active: 2019-2024
Publications (10 Years): 7
Publications (10 Years): 7
Publications
- Medha Barbhaiya, Stéphane Zuily, Ray Naden, Alison Hendry, Florian Manneville, Mary-Carmen Amigo, Zahir Amoura, Danieli Castro de Oliveira Andrade, Laura Andreoli, Bahar Artim-Esen, Tatsuya Atsumi, Tadej Avcin, H Michael Belmont, Maria Laura Bertolaccini, D Ware Branch, Graziela Carvalheiras, Alessandro Casini, Ricard Cervera, Hannah Cohen, Nathalie Costedoat-Chalumeau, Mark Crowther, Guilherme Ribeiro Ramires de Jésus, Aurelien Delluc, Sheetal Desai, Maria De Sancho, Katrien M Devreese, Reyhan Diz-Kucukkaya, Ali Duarte Garcia, Camille Frances, David Garcia, Jean-Christophe Gris, Natasha Jordan, Rebecca K Leaf, Nina Kello, Christian Lood, Carl Laskin, Alfred I Lee, Kimberly Legault, Steve R Levine, Roger Abramino Levy, Maarten Limper, Michael D Lockshin, Karoline Mayer-Pickel, Jack Musial, Pier Luigi Meroni, Giovanni Orsolini, Thomas L Ortel, Vittorio Pengo, Michelle A Petri, Guillermo J Pons-Estel, Jose A Gomez-Puerta, Quentin Raimboug, Robert Roubey, Giovanni Sanna, Surya V Seshan, Savinio Sciascia, Maria G G Tektonidou, Angela Tincani, Denis Wahl, Rohan Willis, Cécile Yelnik, Catherine Zuily, Francis Guillemin, Karen H Costenbader, Doruk Erkan, null null
- Giovanni Orsolini, Francesca Mastropaolo, Eleonora Favaro, Anna Piccinelli, Davide Bertelle, Ombretta Viapiana, Maurizio Rossini, Riccardo Bixio
- Giovanni Adami, Marco Pontalti, Giorgio Cattani, Maurizio Rossini, Ombretta Viapiana, Giovanni Orsolini, Camilla Benini, Eugenia Bertoldo, Elena Fracassi, Davide Gatti, Angelo Fassio
- Alessandro Giollo, Eugenia Bertoldo, Giovanni Adami, Adam J Cybulski, Angelo Fassio, Giovanni Orsolini, Luca Idolazzi, Davide Gatti, Ombretta Viapiana, Maurizio RossiniComment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases. Annals of the rheumatic diseases (2020)
- Giovanni Orsolini, Irene Elizabeth Maria Bultink, Giovanni Adami, Angelo Fassio, Ombretta Viapiana, Alessandro Giollo, Davide Gatti, Maurizio Rossini